Parnax Lab Limited PARNAXLAB NSE
Company Profile ↓Company Overview
Parnax Lab Limited (PARNAXLAB) is a publicly traded company listed on NSE with a market capitalization of ₹154.83 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 11.0% per year over the last five years.
Revenue has grown at a 14.0% CAGR over the past five years.
Trades at an undemanding P/E of 13.4.
Recent Developments
- Mar 2026 Revenue of ₹248.54 Cr (+32.4% YoY); net profit ₹11.78 Cr.
- Trailing 12 Months Year-on-year growth — revenue +32.4%, earnings +2.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 14.0%, profit CAGR 11.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 14.03% |
| 1 Year: | 32.39% |
Compounded Profit Growth
| 5 Years: | 10.97% |
| 1 Year: | 2.24% |
Stock Price Performance
| 1 Year: | +10.49% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 14.0% over 5 years.
- Profit CAGR of 11.0% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 49.04 Cr | 53.38 Cr | 62.60 Cr | 62.94 Cr | 69.63 Cr |
| Cost of Revenue | - | 26.28 Cr | 29.98 Cr | 36.32 Cr | 37.33 Cr | 43.45 Cr |
| Gross Profit | - | 22.76 Cr | 23.39 Cr | 26.28 Cr | 25.61 Cr | 26.17 Cr |
| Operating Expenses | - | 17.95 Cr | 17.90 Cr | 20.30 Cr | 20.72 Cr | 23.33 Cr |
| Operating Income | - | 4.80 Cr | 5.49 Cr | 5.98 Cr | 4.89 Cr | 2.85 Cr |
| EBITDA | - | 7.06 Cr | 7.62 Cr | 8.71 Cr | 6.68 Cr | 6.65 Cr |
| Interest Expense | - | 1.28 Cr | 1.22 Cr | 1.40 Cr | 1.47 Cr | 1.61 Cr |
| Pretax Income | - | 3.95 Cr | 4.46 Cr | 5.20 Cr | 3.25 Cr | 3.00 Cr |
| Tax Provision | - | 1.03 Cr | 1.18 Cr | 1.58 Cr | 53.29 L | 81.38 L |
| Net Income | - | 2.92 Cr | 3.27 Cr | 3.63 Cr | 2.71 Cr | 2.18 Cr |
| Diluted EPS | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 167.61 Cr | 188.71 Cr | 187.74 Cr | 248.54 Cr |
| Cost of Revenue | - | 116.34 Cr | 133.28 Cr | 96.00 Cr | 147.09 Cr |
| Gross Profit | - | 51.27 Cr | 55.43 Cr | 91.74 Cr | 101.45 Cr |
| Operating Expenses | - | 34.52 Cr | 38.76 Cr | 72.35 Cr | 82.25 Cr |
| Operating Income | - | 16.75 Cr | 16.67 Cr | 19.39 Cr | 19.20 Cr |
| EBITDA | - | 23.71 Cr | 24.28 Cr | 28.44 Cr | 29.66 Cr |
| Interest Expense | - | 4.90 Cr | 5.26 Cr | 5.39 Cr | 5.71 Cr |
| Pretax Income | - | 12.28 Cr | 12.05 Cr | 15.67 Cr | 15.91 Cr |
| Tax Provision | - | 3.65 Cr | 2.42 Cr | 4.13 Cr | 4.11 Cr |
| Net Income | - | 8.62 Cr | 9.61 Cr | 11.52 Cr | 11.78 Cr |
| Diluted EPS | 9.68 | 7.79 | 8.37 | 10.05 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 145.07 Cr | 190.26 Cr | 189.82 Cr | 227.63 Cr |
| Current Assets | - | 61.06 Cr | 76.93 Cr | 68.34 Cr | 93.04 Cr |
| Cash & Equivalents | - | 1.28 Cr | 45.78 L | 54.99 L | 33.64 L |
| Inventory | - | 21.69 Cr | 29.93 Cr | 25.77 Cr | 36.22 Cr |
| Receivables | - | 27.89 Cr | 32.56 Cr | 30.76 Cr | 37.81 Cr |
| Total Liabilities | - | 82.81 Cr | 118.57 Cr | 106.58 Cr | 132.33 Cr |
| Current Liabilities | - | 63.04 Cr | 83.33 Cr | 74.33 Cr | 95.85 Cr |
| Long Term Debt | - | 12.02 Cr | 21.05 Cr | 17.99 Cr | 21.73 Cr |
| Total Debt | - | 54.72 Cr | 80.64 Cr | 69.53 Cr | 82.78 Cr |
| Total Equity | - | 62.15 Cr | 71.57 Cr | 83.10 Cr | 95.14 Cr |
| Shares Outstanding | - | 1.15 Cr | 1.15 Cr | 1.15 Cr | 1.15 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 20.91 Cr | 15.88 Cr | 32.30 Cr | 8.00 Cr |
| Investing Cash Flow | - | -9.92 Cr | -31.52 Cr | -16.39 Cr | -16.39 Cr |
| Financing Cash Flow | - | -14.07 Cr | 14.82 Cr | -15.82 Cr | 8.18 Cr |
| Capital Expenditure | - | -11.28 Cr | -32.49 Cr | -18.58 Cr | -17.31 Cr |
| Free Cash Flow | - | 9.63 Cr | -16.62 Cr | 13.72 Cr | -9.31 Cr |
| Net Change in Cash | - | -3.08 Cr | -82.17 L | 9.21 L | -21.35 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 30.6% | 29.4% | 48.9% | 40.8% |
| Operating Margin % | - | 10.0% | 8.8% | 10.3% | 7.7% |
| Net Margin % | - | 5.1% | 5.1% | 6.1% | 4.7% |
| ROE % | - | 13.9% | 13.4% | 13.9% | 12.4% |
| ROCE % | - | 20.4% | 15.6% | 16.8% | 14.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PARNAXLAB
PARNAXLAB Stock Price and Chart — NSE:PARNAXLAB - TradingView
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5TR09RNDRDWlYwX2FQN3ZBNnRNVGlSVDl0ZFlMczc0NjFDUVNQcEdqNUo3Y1dibU05U1hkenJfOW83STNfRy1TbFNPVF93UXl2UVI5R0kwVFN5UzNWY2E0?oc=5" target="_blank">PARNAXLAB Stock Price and Chart — NSE:P…
Parnax Lab schedules 44th AGM on Sep 29 for RPT approval - scanx.trade
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMDc0bDlUbTdJUTlXUk5VVzJjcHRzdmRnRklXMTJCRXhNdTJyNXBHdy10elJ5NXkyTzFWQ0xvZzVfNDRoOWszakFFSkJqN3doaVlKTmNucXRVV0k4Q25TVkJVekRPTE91VUpVdlVud2E3amFmb1F1QnB6d3lLdlBwODA0aVhFWG5SZldFSk…
Parnax Lab Ltd (PARNAXLAB) sentiment score, message volume, participation score and buzz level - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9UdnRCcXp0QjI3dkJrcExWV0g4OTVUdVZXSHozQnVHSW54QnQzNV82M1ZJbWpmeUNfU250dXh5alM2VHAyU3JQVWdpSXV2UVk1Zll0ekpiS2ItN1doRlp1NFVzUQ?oc=5" target="_blank">Parnax Lab Ltd (PARNAXLAB) sentim…
Parnax Lab Ltd (PARNAXLAB) Fundamental and Financial Data - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9sVGlwSmwzQUxtd1RDZWF1VXVsa01yTEMxRE40SE0zaHlIRGJjLXFQV1ljTFhQR3ZZU3hOdWlpcXE0b2tIcDdrNkMtUnd4cENyMDBqdldQZGg2RmdTVlVhTTJXNUtsU2c?oc=5" target="_blank">Parnax Lab Ltd (PARNAXLAB) F…
Parnax Lab Share Price Rises 9.84%: Analysis - Univest
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOaERKdUd3dnMybWc0OUE0Nlk5WWI0Z012RkR1b0NGYWUtcW5LRXlzT1dvUGVyNHpmbjAtQXdCMld1WE52U1RsaWlNUGdYYTRXak8zQVNPanFYS0llVDNOMmdUVmNqbnluOWxfSTNnbk4tRTdYcEw0SDhxblhZd2NvejQ3RQ?oc=5" targe…
Parnax Lab Ltd. Peer Comparison – Compare with Others - Value Research
<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNUo0MjNqMC01STJzTm9KMWRtN3kyYjVLcnhVb2xISWExb2I1TUN1MVdRUEFha3JFc1cyMWVpY0hDV1VIekp4dGFDQzdaUVdXeW1fbGlrRkVLakk1Ml90MWFqUzJWaThzam4xV2xSTmxJenZIbGFqdnRYd084aEdBOHY4ejV1QmFBSkozYn…
PARNAXLAB — Frequently Asked Questions
What is the current share price of Parnax Lab Limited (PARNAXLAB)?
As of 2026-09-08 04:53 IST, Parnax Lab Limited (PARNAXLAB) trades at ₹134.80 on NSE. Its 52-week range is ₹120.24 to ₹140.78.
What is the market capitalisation of PARNAXLAB?
Parnax Lab Limited (PARNAXLAB) has a market capitalisation of ₹154.83 Cr on NSE.
What is the P/E ratio of PARNAXLAB?
PARNAXLAB trades at a trailing price-to-earnings (P/E) ratio of 13.41. Its price-to-book (P/B) ratio is 1.54.
What is the return on equity (ROE) of PARNAXLAB?
PARNAXLAB has a return on equity (ROE) of 12.38%. Its return on capital employed (ROCE) is 14.57%.
Is PARNAXLAB a good stock to buy?
This page provides a data-driven analysis of Parnax Lab Limited (PARNAXLAB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.